Clinical

Dataset Information

0

Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Colorectal Cancer With or Without ACE Polymorphisms


ABSTRACT: The purpose of this study is to assess FOLFIRI+aflibercept efficacy in patients with or without ACE polymorphisms in terms of Progression-free survival (PFS).

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2230383 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2535685 | ecrin-mdr-crc
2013-09-01 | E-GEOD-50519 | biostudies-arrayexpress
2013-09-01 | GSE50519 | GEO
2019-10-01 | GSE124956 | GEO
2021-07-14 | GSE137705 | GEO
2023-05-18 | GSE150794 | GEO
| S-EPMC6700318 | biostudies-literature
| 2254063 | ecrin-mdr-crc
| S-EPMC6426764 | biostudies-literature
2024-05-21 | PXD039210 | Pride